Metastatic bladder giant cell urothelial carcinoma
Clinical trials for Metastatic bladder giant cell urothelial carcinoma explained in plain language.
Never miss a new study
Get alerted when new Metastatic bladder giant cell urothelial carcinoma trials appear
Sign up with your email to follow new studies for Metastatic bladder giant cell urothelial carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare cancers: Triple-Drug attack shows promise
Disease control Recruiting nowThis phase II trial is testing whether a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—can shrink or slow the growth of rare genitourinary cancers that have spread. About 314 adults with these uncommon tumors will receive the drugs. The goal is to see if the …
Matched conditions: METASTATIC BLADDER GIANT CELL UROTHELIAL CARCINOMA
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 22:00 UTC
-
New cocktail of drugs takes on Hard-to-Treat bladder cancer
Disease control Recruiting nowThis early-phase trial tests a combination of three drugs—enfortumab vedotin, pembrolizumab, and quemliclustat—in people with advanced bladder or urinary tract cancer that has spread or cannot be removed by surgery. The goal is to see if the combination is safe and effective. The…
Matched conditions: METASTATIC BLADDER GIANT CELL UROTHELIAL CARCINOMA
Phase 1/2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC